Vertex Pharmaceuticals (NASDAQ: VRTX) fell by 13% on Dec. 19, when the rare-disease drug developer reported some lackluster ...

This was the stock's fourth consecutive day of gains.

NEW YORK, NY / ACCESSWIRE / December 26, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vertex ...

Dow Jones futures fell modestly early Friday, along with S&P 500 futures and Nasdaq futures.The stock market rally shrugged ...

The Food and Drug Administration (FDA) has approved Alyftrek ™ (vanzacaftor/tezacaftor/deutivacaftor) for the treatment of cystic fibrosis (CF) in patients aged 6 years and older who have at least one ...

JMP Securities raised the firm’s price target on Rhythm Pharmaceuticals (RYTM) to $75 from $64 and keeps an Outperform rating on the shares as part of a broader note on Biotechnology.

The main opposition Democratic Party (DP) submitted an impeachment motion against acting President Han Duck-soo and reported it to a parliamentary plenary session Thursday. The ... The ...

A driver involved in a tragic hit-and-run incident in Phuket turned himself into the police. Police confirmed that the driver will face charges for his actions following the fatal accident that ...

Venmax Drugs & Pharmaceuticals Ltd. share price moved up by 4.94% from its previous close of Rs 14.16. Venmax Drugs & Pharmaceuticals Ltd. stock last traded price is 14.86 ...